APA (7th ed.) Citation

M, F., M, L., J, Z., A, L., Y, S., P, S., . . . H, R. (2025). Clinical value of serum PRDM16 in early diagnosis and prognosis assessment of lung adenocarcinoma. Molecular biology reports, 52(1), 225. https://doi.org/10.1007/s11033-025-10315-7

Chicago Style (17th ed.) Citation

M, Fan, Li M, Zhou J, Li A, Sun Y, Shi P, Zhang S, Chen M, and Ren H. "Clinical Value of Serum PRDM16 in Early Diagnosis and Prognosis Assessment of Lung Adenocarcinoma." Molecular Biology Reports 52, no. 1 (2025): 225. https://doi.org/10.1007/s11033-025-10315-7.

MLA (9th ed.) Citation

M, Fan, et al. "Clinical Value of Serum PRDM16 in Early Diagnosis and Prognosis Assessment of Lung Adenocarcinoma." Molecular Biology Reports, vol. 52, no. 1, 2025, p. 225, https://doi.org/10.1007/s11033-025-10315-7.